137
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between Thyroid Parameters and Subclinical Atherosclerosis in Hospitalised Euthyroid Patients with Type 2 Diabetes Mellitus

ORCID Icon, , , &
Pages 3163-3171 | Received 12 Jul 2023, Accepted 04 Oct 2023, Published online: 12 Oct 2023

References

  • Dal Canto E, Ceriello A, Ryden L, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26:25–32. doi:10.1177/2047487319878371
  • Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–2222. doi:10.1016/S0140-6736(10)60484-9
  • Balletshofer B, Bockler D, Diener H, et al. Position paper on the diagnosis and treatment of peripheral arterial disease (PAD) in people with diabetes mellitus. Exp Clin Endocrinol Diabetes. 2022;130:S127–S136. doi:10.1055/a-1624-3631
  • Adedokun TA, Kwaghe VG, Adedokun O, et al. Prevalence and risk factors for subclinical atherosclerosis amongst adults living with HIV in university of abuja teaching hospital, Gwagwalada. Front Reprod Health. 2023;5:1092211. doi:10.3389/frph.2023.1092211
  • Ballotari P, Ranieri SC, Luberto F, et al. Sex differences in cardiovascular mortality in diabetics and nondiabetic subjects: a population-based study (Italy). Int J Endocrinol. 2015;2015:914057. doi:10.1155/2015/914057
  • Gregg EW, Cheng YJ, Srinivasan M, et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet. 2018;391:2430–2440. doi:10.1016/S0140-6736(18)30314-3
  • Bauer M, Caviezel S, Teynor A, et al. Carotid intima-media thickness as a biomarker of subclinical atherosclerosis. Swiss Med Wkly. 2012;142:w13705. doi:10.4414/smw.2012.13705
  • Johri AM, Nambi V, Naqvi TZ, et al. Recommendations for the assessment of carotid arterial plaque by ultrasound for the characterization of atherosclerosis and evaluation of cardiovascular risk: from the American society of echocardiography. J Am Soc Echocardiogr. 2020;33:917–933. doi:10.1016/j.echo.2020.04.021
  • Papadopoulou AM, Bakogiannis N, Skrapari I, et al. Thyroid dysfunction and atherosclerosis: a systematic review. Vivo. 2020;34:3127–3136. doi:10.21873/invivo.12147
  • Hu Y, Hu Z, Tang W, et al. Association of thyroid hormone levels with microvascular complications in euthyroid type 2 diabetes mellitus patients. Diabetes Metab Syndr Obes. 2022;15:2467–2477. doi:10.2147/DMSO.S354872
  • Wang L, Chen T, Yu J, et al. Clinical associations of thyroid hormone levels with the risk of atherosclerosis in euthyroid type 2 diabetic patients in central China. Int J Endocrinol. 2020;2020:2172781. doi:10.1155/2020/2172781
  • Gu Y, Meng G, Zhang Q, et al. Association of longitudinal trends in thyroid function with incident carotid atherosclerosis in middle-aged and older euthyroid subjects: the Tianjin chronic low-grade systemic inflammation and health (TCLSIH) cohort study. Age Ageing. 2022;51:afab276. doi:10.1093/ageing/afab276
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612. doi:10.7326/0003-4819-150-9-200905050-00006
  • Katakami N, Matsuoka TA, Shimomura I. Clinical utility of carotid ultrasonography: application for the management of patients with diabetes. J Diabetes Investig. 2019;10:883–898. doi:10.1111/jdi.13042
  • Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, et al. Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome. Diabetes Care. 2019;42:303–310. doi:10.2337/dc18-1410
  • Cappelli C, Rotondi M, Pirola I, et al. TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care. 2009;32:1589–1590. doi:10.2337/dc09-0273
  • Yagi H, Pohlenz J, Hayashi Y, et al. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3’-triiodothyroinine binding affinity. J Clin Endocrinol Metab. 1997;82:1608–1614. doi:10.1210/jcem.82.5.3945
  • Gao W, Guo W, Guo Y, et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. 2021;44:1031–1040. doi:10.1007/s40618-020-01460-w
  • Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
  • Fan J, Watanabe T. Atherosclerosis: known and unknown. Pathol Int. 2022;72:151–160. doi:10.1111/pin.13202
  • Ning Y, Cheng YJ, Liu LJ, et al. What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1,898,314. BMC Med. 2017;15:21. doi:10.1186/s12916-017-0777-9
  • Peixoto DME, Bittencourt MS, Pereira AC, et al. Subclinical hypothyroidism is associated with higher carotid intima-media thickness in cross-sectional analysis of the Brazilian longitudinal study of adult health (ELSA-Brasil). Nutr Metab Cardiovasc Dis. 2016;26:915–921. doi:10.1016/j.numecd.2016.06.005
  • Gao N, Zhang W, Zhang YZ, et al. Carotid intima-media thickness in patients with subclinical hypothyroidism: a meta-analysis. Atherosclerosis. 2013;227:18–25. doi:10.1016/j.atherosclerosis.2012.10.070
  • Bano A, Chaker L, Mattace-Raso F, et al. Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality: the Rotterdam study. Circ Res. 2017;121:1392–1400. doi:10.1161/CIRCRESAHA.117.311603
  • Gluvic ZM, Zafirovic SS, Obradovic MM, et al. Hypothyroidism and risk of cardiovascular disease. Curr Pharm Des. 2022;28:2065–2072. doi:10.2174/1381612828666220620160516
  • Zhang Y, Lu P, Zhang L, et al. Association between lipids profile and thyroid parameters in euthyroid diabetic subjects: a cross-sectional study. BMC Endocr Disord. 2015;15:12. doi:10.1186/s12902-015-0008-3
  • Razvi S, Jabbar A, Pingitore A, et al. Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol. 2018;71:1781–1796. doi:10.1016/j.jacc.2018.02.045
  • Rajendran S, Shen X, Glawe J, et al. Nitric oxide and hydrogen sulfide regulation of ischemic vascular growth and remodeling. Compr Physiol. 2019;9:1213–1247.
  • Billon C, Canaple L, Fleury S, et al. TRalpha protects against atherosclerosis in male mice: identification of a novel anti-inflammatory property for TRalpha in mice. Endocrinology. 2014;155:2735–2745. doi:10.1210/en.2014-1098
  • Neggazi S, Hamlat N, Canaple L, et al. TRalpha inhibits arterial renin-angiotensin system expression and prevents cholesterol accumulation in vascular smooth muscle cells. Ann Endocrinol. 2019;80:89–95. doi:10.1016/j.ando.2018.09.008
  • Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006;114:597–605. doi:10.1161/CIRCULATIONAHA.106.621854
  • Qu F, Shi Q, Wang Y, et al. Visit-to-visit glycated hemoglobin A1c variability in adults with type 2 diabetes: a systematic review and meta-analysis. Chin Med J. 2022;135:2294–2300. doi:10.1097/CM9.0000000000002073
  • Zhou Y, Huang H, Yan X, et al. Glycated haemoglobin A1c variability score elicits kidney function decline in Chinese people living with type 2 diabetes. J Clin Med. 2022;11:6692. doi:10.3390/jcm11226692
  • Li S, Nemeth I, Donnelly L, et al. Visit-to-Visit HbA(1c) variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2020;43:426–432. doi:10.2337/dc19-0823
  • Yavuz DG, Temizkan S, Yazici D. Serum Carboxymethyl-Lysine and Soluble Receptor for Advanced Glycation end Products in Hyperthyroid and Hypothyroid Patients. Acta Endocrinol. 2022;18:436–441. doi:10.4183/aeb.2022.436
  • Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94:355–382. doi:10.1152/physrev.00030.2013
  • Lin J, Xiang X, Qin Y, et al. Correlation of thyroid-related hormones with vascular complications in type 2 diabetes patients with euthyroid. Front Endocrinol. 2022;13:1037969. doi:10.3389/fendo.2022.1037969
  • Qin K, Zhang F, Wu Q, et al. Thyroid hormone changes in euthyroid patients with diabetes. Diabetes Metab Syndr Obes. 2020;13:2533–2540. doi:10.2147/DMSO.S260039
  • Liu Y, Li Z, Yang T, et al. Impaired sensitivity to thyroid hormones and carotid plaque in patients with coronary heart disease: a RCSCD-TCM study in China. Front Endocrinol. 2022;13:940633. doi:10.3389/fendo.2022.940633